SCHEMBL3299477

SCHEMBL3299477

CS(C)(O[Cl+3]([O-])([O-])[O-])c1ccccc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 4/20 0.36
HTR6 P50406 2/20 0.33
PSIP1 O75475 1/20 0.33
ALDH1A1 P00352 2/20 0.31
HSD17B10 Q99714 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
CA12 O43570 1/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
CA3 P07451 1/20 0.31
CA4 P22748 1/20 0.31
CA6 P23280 1/20 0.31
CA5A P35218 1/20 0.31
CA7 P43166 1/20 0.31
PLA2G7 Q13093 1/20 0.31
CA9 Q16790 1/20 0.31
CA13 Q8N1Q1 1/20 0.31
CA14 Q9ULX7 1/20 0.31
CA5B Q9Y2D0 1/20 0.31
TSHR P16473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3857787 0.82 PTGS2 (0.36) PTGS2HTR6PSIP1ALDH1A1HSD17B10
SCHEMBL8757720 0.82 GAA (0.41) PTGS2ALDH1A1TDP1CA12CA1
SCHEMBL11522694 0.78 KMT2A (0.43) ALDH1A1TDP1SMN1; SMN2KDM4ELMNA
SCHEMBL108184 0.76 HTR6 (0.36) PTGS2HTR6PSIP1ALDH1A1HSD17B10
SCHEMBL3134808 0.72 HTT (0.42) ALDH1A1TDP1CA12CA1CA2
SCHEMBL3135940 0.72 HTT (0.42) ALDH1A1TDP1CA12CA1CA2
SCHEMBL5828197 0.70 CA4 (0.39) PTGS2HTR6PSIP1ALDH1A1HSD17B10
SCHEMBL11656936 0.70 MAPK1 (0.53) PTGS2ALDH1A1CA12CA9TSHR
SCHEMBL3144342 0.70 CA4 (0.46) ALDH1A1TDP1CA12CA1CA2
SCHEMBL3135189 0.70 CA4 (0.46) ALDH1A1TDP1CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0035969-B1 COMPOSITION OF CATIONICALLY POLYMERISABLE MATERIAL AND A CATALYST CIBA-GEIGY AG (CH) 1985-02-13 EP claimed
US-7862980-B2 Salt suitable for an acid generator and a chemically amplified positive resist composition containing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-01-04 US disclosed
US-7741007-B2 Lithography; semiconductor microfabrication SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-06-22 US disclosed
US-7575850-B2 Having acrylic ester functionality with acid labile ester ring functionality and sulfonium sulfonate acid salt; high resolution semiconductor microfabrication patterns; excimer laser lithography SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-08-18 US disclosed
US-7566522-B2 Having acrylic ester functionality with acid labile ester ring functionality and sulfonium sulfonate acid salt; high resolution semiconductor microfabrication patterns; excimer laser lithography SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-28 US disclosed
US-20080213695-A1 Lithography; semiconductor microfabrication SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2008-09-04 US disclosed
US-20080193874-A1 Having acrylic ester functionality with acid labile ester ring functionality and sulfonium sulfonate acid salt; high resolution semiconductor microfabrication patterns; excimer laser lithography SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2008-08-14 US disclosed
US-20080176168-A1 CHEMICALLY AMPLIFIED RESIST COMPOSITION SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2008-07-24 US disclosed
US-20080166660-A1 Having acrylic ester functionality with acid labile ester ring functionality and sulfonium sulfonate acid salt; high resolution semiconductor microfabrication patterns; excimer laser lithography SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2008-07-10 US disclosed
US-20080081293-A1 Salt suitable for an acid generator and a chemically amplified positive resist composition containing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2008-04-03 US disclosed
US-4339567-A Photopolymerization by means of sulphoxonium salts CIBA-GEIGY CORPORATION (US) 1982-07-13 US disclosed
US-4256885-A 5-FLUOROURACIL AND 2,3-DIHYDROFURAN, ACID CATALYSTS MITSUI TOATSU KAGAKU KABUSHIKI KAISHA (JP) 1981-03-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080081293-A1 Salt suitable for an acid generator and a chemically amplified positive resist composition containing the same HCN3, HCN1, NHERF1 PTGS2 2972/4885HTR6 2248/4885PSIP1 3552/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.